Search
About
Our Story
Leadership Team
Board of Directors
3D Technology Platform
3D Bioprinting
High Throughput 3D models
Disease Models: Technology Agnostic
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Investor Kit
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
Search for:
Pioneering 3D Human Tissues for Drug Discovery
News
Nov 15 | 2022
Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates
Read More
»
Sep 06 | 2022
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Read More
»
Sep 06 | 2022
Organovo Announces Postponement of Annual Meeting of Stockholders
Read More
»
About
Our Story
Leadership Team
Board of Directors
3D Technology Platform
3D Bioprinting
High Throughput 3D models
Disease Models: Technology Agnostic
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Investor Kit
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
